Acceleron Pharma Inc - Company Profile
Powered by 
All the sales intelligence you need on Acceleron Pharma Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Acceleron Pharma Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Acceleron Pharma Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Acceleron Pharma Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4081240A4 | Search Report | Zusammensetzungen und verfahren zum behandeln von pulmonaler hypertonie | A61K38/177; A61K38/179; A61K38/1796; A61K38/1875; A61K45/06; A61P11/00; A61P9/12; C07K2319/30 | December 06, 2023 |
| AU2023263573A1 | Application | Compositions and methods for treating pulmonary hypertension | A61K38/179; A61K47/6811; A61P11/00; A61P9/00; A61P9/12; C07K14/71; C07K19/00; C07K2319/30; C07K2319/32 | November 30, 2023 |
| US11827689B2 | Grant | Alk7:actriib heteromultimers and uses thereof | C12N9/12; C12Y207/1103; A61K38/00; A61K38/45; C07K14/71; C07K2319/30 | November 28, 2023 |
| EP4274600A1 | Application | Zusammensetzungen und verfahren zur behandlung von pulmonaler hypertonie | C12Y207/1103; A61K38/179; A61K38/1796; A61K45/06; A61P9/12; C07K14/71; C07K2319/30 | November 15, 2023 |
| US11807673B2 | Grant | Methods and compositions for increasing red blood cells | C07K14/51; C07K2319/02 | November 07, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer